skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

15 studies were found about Specific Populations, Long-Term Nonprogressors/Elite Controllers

HIV Persistence and Viral Reservoirs

Condition: HIV; HIV Infections

NCT ID: NCT01025427

Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors

Condition: HIV Infections

NCT ID: NCT00029445

Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection

Condition: HIV Infection

NCT ID: NCT01065207

Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study

Condition: Immunodeficiency Virus, Human

NCT ID: NCT02081638

Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy

Condition: HIV Infections

NCT ID: NCT00559416

Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda

Condition: HIV; Acquired Immunodeficiency Syndrome; Influenza

NCT ID: NCT01916759

The Use of Leukapheresis to Support HIV Pathogenesis Studies

Condition: HIV

NCT ID: NCT01161199

the " Extreme " Cohort (CODEX)

Condition: HIV Infection

NCT ID: NCT01520844

FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir

Condition: HIV-1 Infection

NCT ID: NCT01777997

Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, China

Condition: HIV Infections

NCT ID: NCT00346762

SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era

Condition: HIV Infections

NCT ID: NCT00187512

Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients

Condition: HIV-1 Infection

NCT ID: NCT02116374

Novel Interventions in HIV-1 Infection

Condition: HIV-1 Infection

NCT ID: NCT01130376

Towards HIV Functional Cure

Condition: Chronic HIV-1 Infection

NCT ID: NCT01876862

A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers

Condition: Healthy; HIV

NCT ID: NCT02018510